Heart Failure - Daniel J Doherty

. .

Résumé :

• Section I - General Introduction


• 1.: Definition of heart failure: basic epidemiology and pathophysiology


• Section II - Chronic Heart Failure


• 2.: Diagnosis and investigation


• 3.: Estimating prognosis


• 4.: Non-pharmacological management


• 5.: Pharmacological management


• 6.: Device therapy


• 7.: Revascularisation


• 8.: Cardiac transplantation


• 9.: Mechanical circulatory support


• Section III - Heart failure and co-morbid/special conditions


• 10.: The patient with heart failure and angina


• 11.: The patient with heart failure and arrhythmias


• 12.: The patient with heart failure and arthritis


• 13.: The patient with heart failure and cancer


• 14.: The patient with heart failure and cardiomyopathy


• 15.: The patient with heart failure and congenital heart disease


• 16.: The patient with heart failure and diabetes mellitus


• 17.: The patient with heart failure and electrolyte disorders


• 18.: The patient with heart failure and infiltrative disease


• 19.: The patient with heart failure and iron deficiency / anaemia


• 20.: The patient with heart failure and myocarditis


• 21.: The patient with heart failure and obstructive lung disease


• 22.: The patient with heart failure and pregnancy


• 23.: The patient with heart failure and renal dysfunction


• 24.: The patient with heart failure and valvular disease


• Section IV - Acute heart failure


• 25.: Definition, aetiology, differing presentations and consequences


• 26.: Management


• Section V - Procedures


• 27.: Central venous cannulation


• 28.: Swan Ganz catheterisation


• 29.: Cardiac biopsy


• 30.: IABP insertion


• 31.: Cardiopulmonary exercise testing


• Section VI - Detailed pharmacology and evidence base for chronic heart failure


• 32.: ACE inhibitors


• 33.: ARNI


• 34.: ARBs


• 35.: Beta-adrenoreceptor antagonists


• 36.: Mineralocorticoid receptor antagonists


• 37.: SGLT2 inhibitors


• 38.: Diuretics and aquaretics


• 39.: Rate limiting agents


• 40.: Inotropes and vasopressors


• 41.: Vasodilators


• Section VI - Multiprofessional heart failure care


• 42.: Heart failure services


• 43.: Palliative care